ANAVEX LIFE SCIENCES CORP. Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year
ANAVEX LIFE SCIENCES CORP. (AVXL) had Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year of $34.23 thousand as of 2017-09-30, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear · last filed 2018-08-09
- 2017-09-30: Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year $34.23K; Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year as first filed $68.46K.
| Period end | Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year | Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year as first filed |
|---|---|---|
| 2017-09-30 | $34.23K 10-Q · filed 2018-08-09 | $68.46K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |